Viking Therapeutics (VKTX) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the ...

Former Minnesota Vikings running back Adrian Peterson stands on the field before an NFL football game between the Vikings and the Chicago Bears, Nov. 27, 2023, in Minneapolis. SUGAR LAND, Texas (AP) — ...

A metal detectorist convicted of stealing part of a Viking hoard valued at £3m is back in jail after not paying back his ...

The Augustana offense flexed once more on Saturday afternoon, knocking off Southwest Minnesota State 57-29 on Mattke Field at ...

Preview the Week 8 matchup between the Los Angeles Chargers and Minnesota Vikings with predictions, odds, over/under, spread, ...

Viking Therapeutics (NASDAQ: VKTX) is set to give its latest quarterly earnings report on Wednesday, 2025-10-22. Here's what ...

The Minnesota Vikings under coach Kevin O'Connell have focused and prided themselves on situational mastery from third downs ...

Keep Saquon Barkley mired in his seasonlong slump and the Vikings beat the Eagles at home. That’s how all of us saw Sunday’s ...

Protecting a three-score lead in the opening seconds of the fourth quarter against Selah, East Valley coach Eric Berg wanted ...

Glendale piled up 267 first-half yards Friday evening at Coach Andy Evanko Stadium, riding a 100-yard rusher and 100-yard ...

Viking Therapeutics is nearing the finish line with a candidate for weight loss -- to potentially enter a drug market that’s approaching $100 billion. This biotech has candidates in phase 2 and phase ...

Viking is developing VK2735, its dual GIP/GLP-1 receptor agonist, in injectable form -- like current marketed weight treatments -- and it's also working on an oral version. The former is involved in a ...